Click to search for your profile
Click to search for condition or expert
Click to open main menu
Save Condition
Bookmark
Share
Share
Condition
Latest Advances in
Spinal Muscular Atrophy Type 3
Overview
Find a Doctor
Latest Advances
Clinical Trials
Latest Advances
Condition:
Spinal Muscular Atrophy Type 3
Journal:
The neurologist
Treatment Used:
Nusinersen
Number of Patients:
1
Published —
September 14, 2020
This case report describes a patient with spinal muscular atrophy type 3 that was treated using nusinersen.
Condition:
Spinal Muscular Atrophy
Journal:
Orphanet journal of rare diseases
Treatment Used:
Nusinersen
Number of Patients:
123
Published —
June 14, 2020
In this study, researchers evaluated the outcomes of using nusinersen for the treatment of spinal muscular atrophy in children.
Condition:
Spinal Muscular Atrophy Type II (SMA)
Journal:
Journal of pediatric orthopedics
Treatment Used:
Magnetically-Controlled Growing Rods (MCGR)
Number of Patients:
11
Published —
June 06, 2020
This study tested the safety and efficacy of using MCGR to treat patients with SMA type II.
Condition:
Adults with Spinal Muscular Atrophy Type 2 and Severe Spinal Deformity
Journal:
European journal of neurology
Treatment Used:
Computed-Tomography-Guided Transforaminal Intrathecal Nusinersen Injection
Number of Patients:
20
Published —
April 07, 2020
The study researched the safety and effectiveness of computed-tomography-guided transforaminal intrathecal nusinersen injection for adults with spinal muscular atrophy type 2 and severe spinal deformity.
Condition:
5q Spinal Muscular Atrophy
Journal:
The Lancet. Neurology
Treatment Used:
Nusinersen
Number of Patients:
139
Published —
March 22, 2020
The purpose of the study was to assess the safety and effectiveness of nusinersen in adults with 5q spinal muscular atrophy.
Condition:
Type 1 Spinal Muscular Atrophy
Journal:
The Journal of pediatrics
Treatment Used:
Nusinersen
Number of Patients:
109
Published —
February 10, 2020
The study researched the effects Nusinersen on respiratory health in patients with type 1 spinal muscular atrophy.
Condition:
Spinal muscular atrophy
Journal:
The Cochrane database of systematic reviews
Treatment Used:
Nusinersen
Number of Patients:
717
Published —
February 02, 2020
The study researched the use of medication in treating patients with spinal muscular atrophy.
Condition:
Chiari Malformation and Syringomyelia Associated with Hirayama Disease
Journal:
World neurosurgery
Treatment Used:
Atlantoaxial and Multisegmental Subaxial Cervical Spinal Fixation
Number of Patients:
1
Published —
December 28, 2019
This case report describes a 23-year-old male diagnosed with a Chiari malformation (brain extending into spinal cord) and syringomyelia (spinal cysts) associated with Hirayama disease (cervical muscle disorder) treated with atlantoaxial and multisegmental subaxial cervical spinal fixation.
Condition:
Spinal muscular atrophy (SMA) Type 1
Journal:
The Cochrane database of systematic reviews
Treatment Used:
Medications
Number of Patients:
121
Published —
December 12, 2019
This review of the literature assessed the effectiveness and safety of any drug therapy designed to slow or arrest progression of spinal muscular atrophy (SMA) type I.
Condition:
Sitting in Patients with Spinal Muscular Atrophy Type 1 (SMA1)
Journal:
Developmental medicine and child neurology
Treatment Used:
Nusinersen
Number of Patients:
50
Published —
December 05, 2019
This study determined factors associated with acquisition of a sitting position in patients with spinal muscular atrophy type 1 (SMA1) treated with nusinersen.
Condition:
Children with Spinal Muscular Atrophy (SMA) and Sleep Disordered Breathing
Journal:
Zhonghua er ke za zhi = Chinese journal of pediatrics
Treatment Used:
Non-Invasive Ventilation Treatment
Number of Patients:
17
Published —
October 10, 2019
This study evaluated the effect of night-time non-invasive ventilation in children with spinal muscular atrophy (SMA) and moderate to severe sleep-disordered breathing.
Condition:
Longstanding Adult 5q-SMA Type 3
Journal:
Journal of neuromuscular diseases
Treatment Used:
Nusinersen
Number of Patients:
19
Published —
October 10, 2019
The study evaluated the safety and treatment effects of Nusinersen in longstanding adult 5q-SMA type 3.
Showing 1-12 of 25
Next